- NCT00000909
A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy
Phase 2Completed - NCT00002140
A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients
Phase 3Completed - NCT00004578
ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects
Phase 1Completed - NCT00004579
A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
Phase 1Completed - NCT00004580
A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors
Phase 1Completed - NCT00004581
A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment
Phase 3Completed - NCT00004582
ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past
Phase 2Completed - NCT00004583
A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy
Phase 3Completed - NCT00004584
Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment
Phase 2Completed - NCT00004585
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
Phase 4Completed - NCT00002071
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
Not ApplicableCompleted - NCT00000680
A Phase I Study of Autologous, Activated CD8(+) Lymphocytes Expanded In Vitro and Infused With or Without Recombinant Interleukin-2 to Patients With AIDS or Severe ARC
Phase 1Completed - NCT00006415
A Study of Patients Who Recently Have Been Infected With HIV
Withdrawn - NCT00006397
Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs
Phase 3Unknown - NCT00006396
Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns
Phase 3Completed - NCT00001071
A Study of Stem Cells and Filgrastim
Not ApplicableCompleted - NCT00000825
The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Phase 2Completed - NCT00006143
Growth Hormone Treatment of Children With HIV-Associated Growth Failure
Not ApplicableCompleted - NCT00006144
A Study of HIV-Disease Development in Aging
Phase 2Completed - NCT00006412
Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids
Phase 3Completed - NCT00006145
Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV
Phase 3Completed - NCT00001079
A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss
Phase 2Completed - NCT00002089
An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy
Not ApplicableCompleted - NCT00006146
Half-Dose Flu Vaccine Study in Healthy Adults
Phase 2Completed - NCT00006578
Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication
Not ApplicableWithdrawn - NCT00006152
A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment
Phase 2Completed - NCT00006290
Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs
Completed - NCT00006298
Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa
Completed - NCT00006441
Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV
Not ApplicableCompleted - NCT00006208
A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
Phase 3Unknown - NCT00006075
A Study of Chlorhexidine in the Prevention of HIV-1 Transmission From Mothers to Their Babies
Phase 2Completed - NCT00006153
Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination
Phase 1Terminated - NCT00006279
The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months
Phase 1Completed - NCT00000728
Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy
Phase 1Completed - NCT00006066
Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems
Phase 1Completed - NCT00000883
Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy
Not ApplicableCompleted - NCT00006064
The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children
Completed - NCT00006339
Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection
Phase 2Withdrawn - NCT00002221
Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma
Phase 2Completed - NCT00005113
A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant
Phase 3Terminated - NCT00006327
Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand
Phase 3Completed - NCT00006304
Long-Term Effects of HIV Exposure and Infection in Children
Completed - NCT00006326
Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir
Not ApplicableTerminated - NCT00006324
Hormonal Birth Control and the Risk of Acquiring HIV
Not ApplicableCompleted - NCT00006316
Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs
Completed - NCT00006207
Safety and Tolerability of the Vaginal Gel PRO 2000/5
Phase 1Completed - NCT00000892
A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir
Not ApplicableCompleted - NCT00006211
A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments
Phase 2Completed - NCT00006209
A Study of Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs
Phase 1Unknown - NCT00016718
Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs
Phase 1Completed - NCT00002072
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
Not ApplicableCompleted - NCT00012519
Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment
Phase 1Completed - NCT00000948
Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Phase 2Completed - NCT00017758
The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs
Phase 1Completed - NCT00001059
Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
Phase 2Completed - NCT00016783
Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV
Completed - NCT00013871
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
Not ApplicableCompleted - NCT00013897
A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine
Phase 3Completed - NCT00012467
Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis
Phase 2Completed - NCT00017771
Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs
Completed - NCT00013585
Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients
Phase 2Completed - NCT00000689
Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma
Phase 1Completed - NCT00014014
Zidovudine and Lamivudine Given Once Versus Twice Daily
Phase 1Completed - NCT00014053
A Study of Immune System Activity in Healthy Adults
Completed - NCT00002009
A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia
Phase 1Completed - NCT00002263
A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine
Not ApplicableCompleted - NCT00002449
Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy
Phase 1Unknown - NCT00002344
A Study of Azithromycin in HIV-Infected Patients
Phase 1Completed - NCT00015691
Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities
Not ApplicableCompleted - NCT00011895
Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
Phase 4Unknown - NCT00001005
A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes
Phase 1Completed - NCT00000899
A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients
Phase 1Completed - NCT00013520
Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection
Phase 3Completed - NCT00016692
Safety and Tolerability of Z-100 in Patients With Early HIV Infection
Phase 1Terminated - NCT00017719
Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
Phase 3Completed - NCT00017797
Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women
Completed - NCT00000873
A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants
Not ApplicableCompleted - NCT00017693
Recombinant Human IL-4 Receptor Used in Treatment of Asthma
Phase 2Completed - NCT00016601
Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women
Not ApplicableCompleted - NCT00000801
Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma
Phase 2Completed - NCT00000889
A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3
Phase 2Completed - NCT00016588
Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs
Not ApplicableCompleted - NCT00000875
Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection
Not ApplicableTerminated - NCT00017784
Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
Phase 3Unknown - NCT00016536
Effects of BufferGel and PRO 2000/5 Gel in Men
Phase 1Completed - NCT00013572
HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults
Phase 1Unknown - NCT00014937
Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen
Not ApplicableCompleted - NCT00000949
A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3
Phase 3Completed - NCT00000681
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
Phase 1Completed - NCT00002085
A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy
Not ApplicableCompleted - NCT00000811
A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
Phase 2Completed - NCT00002082
Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study
Not ApplicableCompleted - NCT00001090
A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase I Trial to Evaluate the Safety and Immunogenicity of Live Recombinant Canarypox ALVAC-HIV vCP205 Combined With GM-CSF in Healthy, HIV-1 Uninfected Volunteers
Phase 1Completed - NCT00000758
A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
Phase 3Completed - NCT00002220
Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir
Phase 3Completed - NCT00002126
A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
Phase 2Completed - NCT00000850
The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy
Phase 2Completed - NCT00002042
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia
Not ApplicableCompleted - NCT00000947
A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
Not ApplicableCompleted - NCT00006154
A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection
Phase 3Completed